C

Chemomab Therapeutics

CMMBNASDAQ

Chemomab Therapeutics is a pharmaceutical preparations company on NASDAQ. As of Q3 2025, 10 institutional investors hold shares in this company, with total holdings valued at $1.0M. SPHERA FUNDS MANAGEMENT LTD. is the largest holder with a position valued at $471.9K.

PHARMACEUTICAL PREPARATIONS
Employees20.0
Country
United States of America

Overview

Overview of institutional ownership in CMMB as of Q3 2025

All Institutions

Institutions
10
Value Held
$1.0M
Shares Held
390.3K
Avg Position
$102.7K
Median Position
$40.8K

Hedge Funds

Hedge Funds
1
Value Held
$140.1K
Shares Held
53.3K
Avg Position
$140.1K
Median Position
$140.1K

Biggest Investors

Institutions with the largest positions in CMMB as of Q3 2025

InstitutionPosition Value
$471.9K
0.11% of portfolio
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
$236.9K
0.00% of portfolio
Ikarian Capital, LLC logo
Ikarian Capital, LLC
Hedge FundEvent Driven
$140.1K
0.03% of portfolio
$78.9K
0.06% of portfolio
$56.6K
0.00% of portfolio
RHUMBLINE ADVISERS logo
RHUMBLINE ADVISERS
Long Only Manager
$25.0K
0.00% of portfolio
$15.1K
0.00% of portfolio
GAMMA Investing LLC logo
GAMMA Investing LLC
Long Only Manager
$1.8K
0.00% of portfolio
UBS Group AG logo
UBS Group AG
Institution
$260.0
0.00% of portfolio
$68.0
0.00% of portfolio

Net Capital Flow

Institutional buying and selling activity for CMMB in Q3 2025

Traded
$3.5M
Buyers
4
Sellers
11
Total Bought
+$320.0K
Total Sold
$3.8M
Avg Position
$68.4K

Biggest Buyers

InstitutionNet Bought
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
+$236.9K
+-1.5M shares
+$78.9K
+30.0K shares
+$2.5K
+942.0 shares
GAMMA Investing LLC logo
GAMMA Investing LLC
Long Only Manager
+$1.8K
+-12.1K shares

Biggest Sellers

InstitutionNet Sold
$1.5M
558.6K shares
ORBIMED ADVISORS LLC logo
ORBIMED ADVISORS LLC
Hedge FundSector
$1.1M
941.0K shares
$670.8K
578.3K shares
Ikarian Capital, LLC logo
Ikarian Capital, LLC
Hedge FundEvent Driven
$420.2K
159.8K shares
RHUMBLINE ADVISERS logo
RHUMBLINE ADVISERS
Long Only Manager
$79.9K
30.4K shares
$36.2K
31.2K shares
$30.4K
26.2K shares
$21.4K
8.2K shares
$1.4K
1.2K shares
UBS Group AG logo
UBS Group AG
Institution
$782.6
298.0 shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited CMMB in Q3 2025

New Positions
1
New Value
$78.9K
Exited Positions
5
Exited Value
$1.8M

New Positions

InstitutionPosition Value
$78.9K
30.0K shares

Exited Positions

InstitutionPrevious Position
ORBIMED ADVISORS LLC logo
ORBIMED ADVISORS LLC
Hedge FundSector
$1.1M
941.0K shares
$670.8K
578.3K shares
$36.2K
31.2K shares
$30.4K
26.2K shares
$1.4K
1.2K shares

Options Activity

Institutions with the largest Call and Put options positions in CMMB as of Q3 2025

Call Positions
0
Call Value
-
Put Positions
0
Put Value
-

Call Positions

InstitutionPosition Value
No call positions found

Put Positions

InstitutionPosition Value
No put positions found

Most Committed Institutions

Institutions with CMMB as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
0.11%
$471.9K
0.06%
$78.9K
Ikarian Capital, LLC logo
Ikarian Capital, LLC
Hedge FundEvent Driven
0.03%
$140.1K
GAMMA Investing LLC logo
GAMMA Investing LLC
Long Only Manager
0.00%
$1.8K
0.00%
$56.6K
RHUMBLINE ADVISERS logo
RHUMBLINE ADVISERS
Long Only Manager
0.00%
$25.0K
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
0.00%
$236.9K
0.00%
$15.1K
0.00%
$68.0
UBS Group AG logo
UBS Group AG
Institution
0.00%
$260.0

Hedge Fund Spotlight

Discover hedge funds investing in CMMB

Ikarian Capital, LLC logo
Ikarian Capital, LLC
Hedge FundEvent Driven
Portfolio ManagerNeil Tristan Shahrestani
Portfolio Value
$494.3M
Positions
116
Last Reported
Q3 2025
AddressDallas, TX
Sector Allocation
Healthcare: 71.90%HealthcareETF: 0.80%
C

Position in Chemomab Therapeutics

Market Value
$140.1K
Shares Held
53.3K
Portfolio Weight
0.03%
Owned Since
2022-Q4
Top HoldingSectorMarket ValueWeight
1
GMAB
Unknown
Unknown
$53.0M10.73%
2
ABVX
Abivax
ABVX
Unknown
Unknown
$33.4M6.76%
Biotechnology
Healthcare
$27.2M5.49%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.